US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Kyverna Therapeutics

6.52

-0.2800-4.12%

Post-market: 6.520.0001+0.00%17:28 EDT

Volume:787.50K

Turnover:5.23M

Market Cap:403.22M

PE:-2.26

High:6.91

Open:6.80

Low:6.51

Close:6.80

52wk High:13.67

52wk Low:5.30

Shares:61.84M

Float Shares:39.72M

Volume Ratio:0.54

T/O Rate:1.98%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.8809

EPS(LYR):-3.6445

ROE:-87.24%

ROA:-44.51%

PB:2.44

PE(LYR):-1.79

Loading ...

Overview Company News Filings

Kyverna Therapeutics Q1 EPS $(0.66) Beats $(0.73) Estimate

Benzinga Earnings

Kyverna Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Kyverna Q1 FY26 net loss narrows to $39.7 million

Kyverna Therapeutics Announces Initiation of Rolling SPS BLA Submission and Reports First Quarter 2026 Financial Results

Kyverna Therapeutics Inc expected to post a loss of 75 cents a share - Earnings Preview

Kyverna Therapeutics Chief Commercial Officer Nadia Dac files initial beneficial ownership statement

Press Release: Kyverna Therapeutics Appoints Nadia Dac, Seasoned Commercial Leader in Neurology and Rare Disease, as Chief Commercial Officer

Kyverna Therapeutics Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Kyverna Therapeutics: Strong CAR‑T Efficacy and Safety in SPS and gMG Underpin Buy Rating and $20 Target

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, AT&T, Yesway

Kyverna Therapeutics Shares Rise 7.3% After Co's Rare Muscle Disorder Cell Therapy Shows Strong Mid-Stage Results

THOMSON REUTERS

BUZZ-U.S. STOCKS ON THE MOVE-Adobe, GE Vernova, Calix

Top Premarket Gainers

MT Newswires Live

Kyverna Shares Rise Premarket After Promising Trial of Neurological Product

BUZZ-Kyverna jumps as rare muscle disorder cell therapy shows strong mid-stage results

Kyverna Therapeutics Shares Jump 21% Premarket After Co's Therapy Improves Mobility in Mid-Stage Stiff Person Syndrome Trial

THOMSON REUTERS

Kyverna Therapeutics (KYTX) Stock Surges 24% After Hours: Why Is It Moving?

Benzinga Earnings

BRIEF-Kyverna Therapeutics Announces Positive Primary Analysis Results From KYSA-8 Trial Of Miv-Cel In SPS

Kyverna Therapeutics Inc - Trial Meets All Secondary Endpoints With Significant Improvements in SPS

THOMSON REUTERS

Kyverna Therapeutics Inc - Announces Positive Primary Analysis Results From Kysa-8 Trial of Miv-Cel in SPS

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/KYTX/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KYTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYTX\",,,,,undefined,":{"symbol":"KYTX","market":"US","secType":"STK","nameCN":"Kyverna Therapeutics","latestPrice":6.52,"timestamp":1790884800000,"preClose":6.8,"halted":0,"volume":787498,"hourTrading":{"tag":"盘后","latestPrice":6.5201,"preClose":6.52,"latestTime":"17:28 EDT","volume":37607,"amount":245287.3552592,"timestamp":1790890126399,"change":0.0001,"changeRate":0.000015,"amplitude":0.014417},"delay":0,"changeRate":-0.041176470588235335,"floatShares":39715000,"shares":61843444,"eps":-2.880877,"marketStatus":"Post-Mkt","change":-0.28,"latestTime":"10-01 17:54:17 EDT","open":6.8,"high":6.91,"low":6.51,"amount":5232561.96092,"amplitude":0.058824,"askPrice":6.64,"askSize":200,"bidPrice":6.5,"bidSize":1045,"shortable":3,"etf":0,"ttmEps":-2.880877,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790899200000},"marketStatusCode":4,"adr":0,"listingDate":1707368400000,"exchange":"NASDAQ","adjPreClose":6.8,"preHourTrading":{"tag":"盘前","latestPrice":6.8,"preClose":6.8,"latestTime":"09:26 EDT","volume":14814,"amount":100733.97043799999,"timestamp":1790861172245,"change":0,"changeRate":0,"amplitude":0.004412},"postHourTrading":{"tag":"盘后","latestPrice":6.5201,"preClose":6.52,"latestTime":"17:28 EDT","volume":37607,"amount":245287.3552592,"timestamp":1790890126399,"change":0.0001,"changeRate":0.000015,"amplitude":0.014417},"volumeRatio":0.535478,"impliedVol":1.6205,"impliedVolPercentile":0.753},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KYTX\",,,,,undefined,":{"symbol":"KYTX","floatShares":39715000,"roa":"-44.51%","roe":"-87.24%","lyrEps":-3.644532,"volumeRatio":0.535478,"shares":61843444,"dividePrice":0,"high":6.91,"amplitude":0.058824,"preClose":6.8,"low":6.51,"week52Low":5.3,"pbRate":"2.44","psRate":"1429.86","week52High":13.67,"institutionHeld":0,"latestPrice":6.52,"committee":0.678715,"eps":-2.880877,"divideRate":0,"volume":787498,"delay":0,"ttmEps":-2.880877,"open":6.8,"prevYearClose":9.4,"prevWeekClose":6.81,"prevMonthClose":6.8,"prevQuarterClose":6.8,"fiveDayClose":6.99,"twentyDayClose":8.615,"sixtyDayClose":9.91},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KYTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"KYTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.67,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"post","actualEps":-0.63},{"market":"US","date":"2026-05-12","symbol":"KYTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.75,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.66},{"market":"US","date":"2026-03-26","symbol":"KYTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.8,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774497600000,"reportTimeType":"post","actualEps":-0.8},{"market":"US","date":"2025-11-12","symbol":"KYTX","fiscalQuarterEnding":"2025/09","expectedEps":-0.97,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.85},{"market":"US","date":"2025-08-12","symbol":"KYTX","fiscalQuarterEnding":"2025/06","expectedEps":1,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"post","actualEps":-0.97}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KYTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KYTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1755748800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KYTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KYTX","date":"2026-09-30","current":-2.311796,"percent":0.543116,"low":-26.836094,"twenty":-4.178413,"median":-2.87543,"eighty":-1.131424,"high":-0.615209,"avg":-4.27898,"sd":5.581135,"marketCap":423009156},"quantilePoints":[{"date":"2024-02-09","current":-25.410847,"twenty":-24.055602,"median":-22.022734,"eighty":-19.989866,"marketCap":1224675750},{"date":"2024-02-16","current":-26.541682,"twenty":-26.641604,"median":-26.505996,"eighty":-25.427787,"marketCap":1279176368},{"date":"2024-02-23","current":-24.230994,"twenty":-26.541682,"median":-25.495549,"eighty":-24.578936,"marketCap":1167812779},{"date":"2024-03-01","current":-24.239916,"twenty":-26.505996,"median":-25.105309,"eighty":-24.54325,"marketCap":1168242754},{"date":"2024-03-08","current":-25.676289,"twenty":-26.318643,"median":-25.069622,"eighty":-24.578936,"marketCap":1237468769},{"date":"2024-03-15","current":-26.354329,"twenty":-26.354329,"median":-25.311608,"eighty":-24.712759,"marketCap":1270146888},{"date":"2024-03-22","current":-23.999034,"twenty":-26.354329,"median":-25.16776,"eighty":-24.239916,"marketCap":1156633422},{"date":"2024-03-28","current":-17.2201,"twenty":-26.32578,"median":-25.042858,"eighty":-23.820602,"marketCap":1039508532},{"date":"2024-04-05","current":-15.927342,"twenty":-26.311505,"median":-24.815357,"eighty":-20.313915,"marketCap":961469941},{"date":"2024-04-12","current":-17.062969,"twenty":-25.959995,"median":-24.578936,"eighty":-17.608641,"marketCap":1030023179},{"date":"2024-04-19","current":-13.577524,"twenty":-25.715544,"median":-24.235455,"eighty":-16.573007,"marketCap":819620788},{"date":"2024-04-26","current":-11.384836,"twenty":-25.597779,"median":-23.86521,"eighty":-16.071617,"marketCap":687256989},{"date":"2024-05-03","current":-10.734886,"twenty":-25.51207,"median":-23.093494,"eighty":-15.443094,"marketCap":648022117},{"date":"2024-05-10","current":-10.427767,"twenty":-25.427787,"median":-18.634621,"eighty":-13.461819,"marketCap":629482562},{"date":"2024-05-17","current":-8.660987,"twenty":-25.252064,"median":-17.663681,"eighty":-11.317698,"marketCap":657507471},{"date":"2024-05-24","current":-7.059414,"twenty":-25.176682,"median":-17.2201,"eighty":-10.732029,"marketCap":535922482},{"date":"2024-05-31","current":-7.116207,"twenty":-25.108877,"median":-16.627288,"eighty":-10.256351,"marketCap":540234007},{"date":"2024-06-07","current":-7.456968,"twenty":-25.053564,"median":-16.309455,"eighty":-9.030538,"marketCap":566103153},{"date":"2024-06-14","current":-5.412407,"twenty":-25.026799,"median":-16.020192,"eighty":-8.479248,"marketCap":410888275},{"date":"2024-06-21","current":-4.390126,"twenty":-24.958995,"median":-15.870204,"eighty":-7.953341,"marketCap":333280836},{"date":"2024-06-28","current":-4.259502,"twenty":-24.826956,"median":-14.259614,"eighty":-7.613717,"marketCap":323364330},{"date":"2024-07-05","current":-3.978375,"twenty":-24.748445,"median":-13.641804,"eighty":-7.429707,"marketCap":302022284},{"date":"2024-07-12","current":-5.56007,"twenty":-24.685994,"median":-12.649024,"eighty":-7.150283,"marketCap":422098238},{"date":"2024-07-19","current":-5.685015,"twenty":-24.571799,"median":-11.216991,"eighty":-6.028046,"marketCap":431583592},{"date":"2024-07-26","current":-5.588466,"twenty":-24.482583,"median":-10.813451,"eighty":-5.596417,"marketCap":424254000},{"date":"2024-08-02","current":-4.117518,"twenty":-24.238132,"median":-10.584898,"eighty":-5.421494,"marketCap":312585519},{"date":"2024-08-09","current":-3.725644,"twenty":-24.184602,"median":-9.999228,"eighty":-5.056881,"marketCap":282836000},{"date":"2024-08-16","current":-3.830678,"twenty":-23.972269,"median":-9.395703,"eighty":-4.700218,"marketCap":290809782},{"date":"2024-08-23","current":-4.597951,"twenty":-23.820602,"median":-8.80297,"eighty":-4.562778,"marketCap":349058032},{"date":"2024-08-30","current":-4.56385,"twenty":-23.561877,"median":-8.433813,"eighty":-4.558634,"marketCap":346469221},{"date":"2024-09-06","current":-4.171688,"twenty":-23.2407,"median":-8.189602,"eighty":-4.480996,"marketCap":316697893},{"date":"2024-09-13","current":-4.092119,"twenty":-22.946288,"median":-7.78069,"eighty":-4.395806,"marketCap":310657334},{"date":"2024-09-20","current":-3.631756,"twenty":-20.733738,"median":-7.624508,"eighty":-4.308092,"marketCap":275708384},{"date":"2024-09-27","current":-2.97247,"twenty":-18.634621,"median":-7.456968,"eighty":-4.211473,"marketCap":225658035},{"date":"2024-10-04","current":-2.63146,"twenty":-17.741488,"median":-7.394495,"eighty":-4.171688,"marketCap":199769924},{"date":"2024-10-11","current":-2.983837,"twenty":-17.707293,"median":-7.116207,"eighty":-4.052335,"marketCap":226520973},{"date":"2024-10-18","current":-3.205494,"twenty":-17.620069,"median":-6.641982,"eighty":-3.978375,"marketCap":243348245},{"date":"2024-10-25","current":-2.909952,"twenty":-17.56293,"median":-5.951944,"eighty":-3.964176,"marketCap":220911882},{"date":"2024-11-01","current":-2.779231,"twenty":-17.2201,"median":-5.608344,"eighty":-3.873307,"marketCap":210988106},{"date":"2024-11-08","current":-3.006571,"twenty":-17.062969,"median":-5.514635,"eighty":-3.751109,"marketCap":228246847},{"date":"2024-11-15","current":-1.697135,"twenty":-16.627288,"median":-5.392529,"eighty":-3.322005,"marketCap":187796512},{"date":"2024-11-22","current":-1.712741,"twenty":-16.355881,"median":-5.065967,"eighty":-3.177076,"marketCap":189523376},{"date":"2024-11-29","current":-2.251143,"twenty":-16.350167,"median":-4.969419,"eighty":-3.054313,"marketCap":249100201},{"date":"2024-12-06","current":-1.775165,"twenty":-16.285886,"median":-4.789428,"eighty":-3.003161,"marketCap":196430834},{"date":"2024-12-13","current":-1.724446,"twenty":-16.121613,"median":-4.674093,"eighty":-2.977017,"marketCap":190818525},{"date":"2024-12-20","current":-1.560584,"twenty":-16.033048,"median":-4.573541,"eighty":-2.950873,"marketCap":172686448},{"date":"2024-12-27","current":-1.556683,"twenty":-15.964482,"median":-4.562178,"eighty":-2.903132,"marketCap":172254731},{"date":"2025-01-03","current":-1.599599,"twenty":-15.904487,"median":-4.538274,"eighty":-2.797418,"marketCap":177003609},{"date":"2025-01-10","current":-1.346004,"twenty":-15.82735,"median":-4.480996,"eighty":-2.693979,"marketCap":148942061},{"date":"2025-01-17","current":-1.299186,"twenty":-15.443094,"median":-4.435561,"eighty":-2.615547,"marketCap":143761467},{"date":"2025-01-24","current":-1.404526,"twenty":-14.591731,"median":-4.395806,"eighty":-2.532048,"marketCap":155417803},{"date":"2025-01-31","current":-1.264073,"twenty":-13.927497,"median":-4.353211,"eighty":-2.095084,"marketCap":139876022},{"date":"2025-02-07","current":-1.170438,"twenty":-13.706085,"median":-4.259502,"eighty":-1.931223,"marketCap":129514836},{"date":"2025-02-14","current":-1.182143,"twenty":-13.577524,"median":-4.21845,"eighty":-1.814179,"marketCap":130809984},{"date":"2025-02-21","current":-1.084606,"twenty":-13.114702,"median":-4.187318,"eighty":-1.73693,"marketCap":120017081},{"date":"2025-02-28","current":-1.108015,"twenty":-12.719019,"median":-4.171688,"eighty":-1.688552,"marketCap":122607378},{"date":"2025-03-07","current":-1.01438,"twenty":-12.020501,"median":-4.104819,"eighty":-1.598038,"marketCap":112246191},{"date":"2025-03-14","current":-0.975365,"twenty":-11.480543,"median":-3.998252,"eighty":-1.555903,"marketCap":107929030},{"date":"2025-03-21","current":-0.928548,"twenty":-11.116285,"median":-3.978412,"eighty":-1.525471,"marketCap":102748436},{"date":"2025-03-28","current":-0.678003,"twenty":-10.923443,"median":-3.972766,"eighty":-1.481775,"marketCap":86429836},{"date":"2025-04-04","current":-0.671223,"twenty":-10.829164,"median":-3.959945,"eighty":-1.403746,"marketCap":85565537},{"date":"2025-04-11","current":-0.698343,"twenty":-10.750599,"median":-3.915931,"eighty":-1.33508,"marketCap":89022731},{"date":"2025-04-17","current":-0.630601,"twenty":-10.726315,"median":-3.836362,"eighty":-1.299186,"marketCap":80387103},{"date":"2025-04-25","current":-0.711969,"twenty":-10.557757,"median":-3.76816,"eighty":-1.283581,"marketCap":90759633},{"date":"2025-05-02","current":-0.772995,"twenty":-10.436338,"median":-3.711325,"eighty":-1.243785,"marketCap":98539030},{"date":"2025-05-09","current":-0.715359,"twenty":-10.170644,"median":-3.266591,"eighty":-1.184484,"marketCap":91191822},{"date":"2025-05-16","current":-0.68951,"twenty":-9.982087,"median":-3.188443,"eighty":-1.152492,"marketCap":100267785},{"date":"2025-05-23","current":-0.73409,"twenty":-9.837812,"median":-3.142975,"eighty":-1.119719,"marketCap":106750616},{"date":"2025-05-30","current":-0.781642,"twenty":-9.466412,"median":-3.049198,"eighty":-1.09553,"marketCap":113665635},{"date":"2025-06-06","current":-0.873775,"twenty":-9.030538,"median":-3.023622,"eighty":-1.030766,"marketCap":127063486},{"date":"2025-06-13","current":-1.02832,"twenty":-8.929052,"median":-2.986679,"eighty":-1.018767,"marketCap":149537300},{"date":"2025-06-20","current":-0.864859,"twenty":-8.793883,"median":-2.980995,"eighty":-1.008108,"marketCap":125766920},{"date":"2025-06-27","current":-1.031292,"twenty":-8.738225,"median":-2.966787,"eighty":-0.98785,"marketCap":149969489},{"date":"2025-07-03","current":-0.835139,"twenty":-8.660987,"median":-2.95542,"eighty":-0.975365,"marketCap":121445033},{"date":"2025-07-11","current":-1.061012,"twenty":-8.20664,"median":-2.912794,"eighty":-0.974824,"marketCap":154291376},{"date":"2025-07-18","current":-1.209614,"twenty":-8.200961,"median":-2.836066,"eighty":-0.975365,"marketCap":175900813},{"date":"2025-07-25","current":-1.260138,"twenty":-8.178243,"median":-2.779231,"eighty":-0.975365,"marketCap":183248021},{"date":"2025-08-01","current":-1.061012,"twenty":-7.803407,"median":-2.688295,"eighty":-0.975365,"marketCap":154291376},{"date":"2025-08-08","current":-0.98374,"twenty":-7.78069,"median":-2.625776,"eighty":-0.98374,"marketCap":143054469},{"date":"2025-08-15","current":-0.964666,"twenty":-7.68982,"median":-2.585992,"eighty":-0.974824,"marketCap":153089661},{"date":"2025-08-22","current":-0.975567,"twenty":-7.678462,"median":-2.530603,"eighty":-0.962936,"marketCap":154819487},{"date":"2025-08-29","current":-1.008267,"twenty":-7.570554,"median":-2.118493,"eighty":-0.964666,"marketCap":160008967},{"date":"2025-09-05","current":-0.989192,"twenty":-7.52512,"median":-1.993646,"eighty":-0.964666,"marketCap":156981771},{"date":"2025-09-12","current":-1.130894,"twenty":-7.468327,"median":-1.952681,"eighty":-0.972792,"marketCap":179469518},{"date":"2025-09-19","current":-1.365248,"twenty":-7.429707,"median":-1.872701,"eighty":-0.975257,"marketCap":216660791},{"date":"2025-09-26","current":-1.730404,"twenty":-7.422892,"median":-1.802474,"eighty":-0.975365,"marketCap":274609985},{"date":"2025-10-03","current":-1.656828,"twenty":-7.377457,"median":-1.775165,"eighty":-0.975365,"marketCap":262933655},{"date":"2025-10-10","current":-1.923883,"twenty":-7.30249,"median":-1.765048,"eighty":-0.975527,"marketCap":305314409},{"date":"2025-10-17","current":-1.910257,"twenty":-7.150283,"median":-1.79077,"eighty":-0.977747,"marketCap":303152125},{"date":"2025-10-24","current":-1.74403,"twenty":-7.070773,"median":-1.806706,"eighty":-0.98265,"marketCap":276772268},{"date":"2025-10-31","current":-1.839406,"twenty":-7.009436,"median":-1.817606,"eighty":-0.98374,"marketCap":291908252},{"date":"2025-11-07","current":-1.932058,"twenty":-6.429007,"median":-1.834596,"eighty":-0.986404,"marketCap":306611779},{"date":"2025-11-14","current":-1.76583,"twenty":-6.028046,"median":-1.829785,"eighty":-0.98707,"marketCap":280231922},{"date":"2025-11-21","current":-2.023973,"twenty":-5.954216,"median":-1.856881,"eighty":-0.988768,"marketCap":325843504},{"date":"2025-11-28","current":-2.086542,"twenty":-5.791787,"median":-1.873766,"eighty":-0.989487,"marketCap":335916623},{"date":"2025-12-05","current":-2.132789,"twenty":-5.650939,"median":-1.874832,"eighty":-0.990456,"marketCap":343361972},{"date":"2025-12-12","current":-2.27425,"twenty":-5.604368,"median":-1.895008,"eighty":-0.995653,"marketCap":366135981},{"date":"2025-12-19","current":-1.904276,"twenty":-5.571428,"median":-1.899357,"eighty":-1.000453,"marketCap":306573190},{"date":"2025-12-26","current":-2.445634,"twenty":-5.541896,"median":-1.907532,"eighty":-1.00316,"marketCap":393727568},{"date":"2026-01-02","current":-3.335677,"twenty":-5.503276,"median":-1.923883,"eighty":-1.005937,"marketCap":537017328},{"date":"2026-01-09","current":-2.998561,"twenty":-5.448754,"median":-1.93164,"eighty":-1.007666,"marketCap":482744300},{"date":"2026-01-16","current":-3.094373,"twenty":-5.404456,"median":-1.947802,"eighty":-1.008709,"marketCap":498169266},{"date":"2026-01-23","current":-3.729571,"twenty":-5.372651,"median":-1.953858,"eighty":-1.010478,"marketCap":600431076},{"date":"2026-01-30","current":-2.913395,"twenty":-5.344255,"median":-1.965361,"eighty":-1.010992,"marketCap":469033219},{"date":"2026-02-06","current":-2.579827,"twenty":-5.065967,"median":-1.978384,"eighty":-1.01346,"marketCap":415331486},{"date":"2026-02-13","current":-2.611764,"twenty":-5.054609,"median":-2.003915,"eighty":-1.013717,"marketCap":420473142},{"date":"2026-02-20","current":-2.87436,"twenty":-4.986457,"median":-2.025703,"eighty":-1.014247,"marketCap":462748974},{"date":"2026-02-27","current":-2.881457,"twenty":-4.928528,"median":-2.043785,"eighty":-1.01438,"marketCap":463891564},{"date":"2026-03-06","current":-2.977269,"twenty":-4.827435,"median":-2.086542,"eighty":-1.020777,"marketCap":479316530},{"date":"2026-03-13","current":-3.112116,"twenty":-4.780255,"median":-2.118493,"eighty":-1.024754,"marketCap":501025741},{"date":"2026-03-20","current":-3.030498,"twenty":-4.769593,"median":-2.129165,"eighty":-1.025937,"marketCap":487885955},{"date":"2026-03-27","current":-3.012142,"twenty":-4.692966,"median":-2.151832,"eighty":-1.027873,"marketCap":484930840},{"date":"2026-04-02","current":-3.286851,"twenty":-4.628408,"median":-2.225282,"eighty":-1.029368,"marketCap":530192007},{"date":"2026-04-10","current":-3.590425,"twenty":-4.584311,"median":-2.250455,"eighty":-1.030802,"marketCap":579160710},{"date":"2026-04-17","current":-3.571686,"twenty":-4.573206,"median":-2.388506,"eighty":-1.03519,"marketCap":576137951},{"date":"2026-04-24","current":-3.358479,"twenty":-4.567056,"median":-2.487395,"eighty":-1.037789,"marketCap":541746122},{"date":"2026-05-01","current":-3.302191,"twenty":-4.561844,"median":-2.543569,"eighty":-1.038061,"marketCap":532666578},{"date":"2026-05-08","current":-3.489816,"twenty":-4.559102,"median":-2.569768,"eighty":-1.044783,"marketCap":562931724},{"date":"2026-05-15","current":-4.15662,"twenty":-4.534296,"median":-2.581654,"eighty":-1.052413,"marketCap":650095346},{"date":"2026-05-22","current":-3.444499,"twenty":-4.49595,"median":-2.613087,"eighty":-1.058444,"marketCap":538719607},{"date":"2026-05-29","current":-3.347743,"twenty":-4.480996,"median":-2.625776,"eighty":-1.061012,"marketCap":523587034},{"date":"2026-06-05","current":-3.076828,"twenty":-4.471909,"median":-2.688295,"eighty":-1.061714,"marketCap":481215829},{"date":"2026-06-12","current":-3.045866,"twenty":-4.449191,"median":-2.698705,"eighty":-1.063858,"marketCap":476373405},{"date":"2026-06-18","current":-3.11166,"twenty":-4.431665,"median":-2.713919,"eighty":-1.066038,"marketCap":486663555},{"date":"2026-06-26","current":-3.187473,"twenty":-4.412024,"median":-2.725319,"eighty":-1.06856,"marketCap":498520738},{"date":"2026-07-02","current":-3.280765,"twenty":-4.395806,"median":-2.779231,"eighty":-1.069929,"marketCap":513111589},{"date":"2026-07-10","current":-3.813306,"twenty":-4.390126,"median":-2.789213,"eighty":-1.073668,"marketCap":596401029},{"date":"2026-07-17","current":-2.892048,"twenty":-4.36173,"median":-2.806937,"eighty":-1.084606,"marketCap":452316377},{"date":"2026-07-24","current":-2.833741,"twenty":-4.344692,"median":-2.815944,"eighty":-1.092409,"marketCap":443197095},{"date":"2026-07-31","current":-2.911484,"twenty":-4.315412,"median":-2.817583,"eighty":-1.094857,"marketCap":455356137},{"date":"2026-08-07","current":-3.01255,"twenty":-4.26922,"median":-2.824699,"eighty":-1.099263,"marketCap":471162893},{"date":"2026-08-14","current":-3.273726,"twenty":-4.239266,"median":-2.836847,"eighty":-1.106454,"marketCap":499695027},{"date":"2026-08-21","current":-3.293984,"twenty":-4.227182,"median":-2.842423,"eighty":-1.108015,"marketCap":502787199},{"date":"2026-08-28","current":-3.500618,"twenty":-4.222326,"median":-2.869037,"eighty":-1.115418,"marketCap":534327356},{"date":"2026-09-04","current":-3.383121,"twenty":-4.213489,"median":-2.87436,"eighty":-1.117439,"marketCap":516392757},{"date":"2026-09-11","current":-2.977956,"twenty":-4.201242,"median":-2.881457,"eighty":-1.123506,"marketCap":454549313},{"date":"2026-09-18","current":-2.852356,"twenty":-4.185897,"median":-2.878979,"eighty":-1.129545,"marketCap":435377845},{"date":"2026-09-25","current":-2.832097,"twenty":-4.18008,"median":-2.881457,"eighty":-1.131212,"marketCap":432285673},{"date":"2026-09-30","current":-2.771323,"twenty":-4.178413,"median":-2.87543,"eighty":-1.131424,"marketCap":423009156}],"updateTime":1790879871817},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KYTX\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635228651","title":"Kyverna Therapeutics Q1 EPS $(0.66) Beats $(0.73) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635228651","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635228651?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:40","pubTimestamp":1778618425,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics (NASDAQ:KYTX) reported quarterly losses of $(0.66) per share which beat the analyst consensus estimate of $(0.73) by 9.59 percent. This is a 35.92 percent increase over losses of $(1.03) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52508030/kyverna-therapeutics-q1-eps-0-66-beats-0-73-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Kyverna Therapeutics Q1 EPS $(0.66) Beats $(0.73) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635924066","title":"Kyverna Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635924066","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635924066?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:20","pubTimestamp":1778617208,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryKyverna Therapeutics Inc KYTX.OQ reported a quarterly adjusted loss of 66 cents per share for the quarter ende","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL8N41P31V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KYTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635224270","title":"Kyverna Q1 FY26 net loss narrows to $39.7 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635224270","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635224270?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:03","pubTimestamp":1778616220,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics posted a net loss of USD 39.7 million, or USD 0.66 per share, for first-quarter 2026.R&D expense fell to USD 30.1 million from USD 37.43 million a year earlier, while G&A expense rose to USD 11.3 million from USD 9.98 million.Cash, cash equivalents, and marketable securities declined to USD 236.4 million as of March 31, 2026; cash runway forecast remains into 2028.Rolling BLA submission for miv-cel in stiff person syndrome began following FDA alignment that the KYSA-8 single-arm Phase 2 trial can support the filing; completion expected in Q4 2026 with priority review sought under RMAT.Launch preparations for stiff person syndrome continue for 2027, while enrollment advances in the Phase 3 portion of the KYSA-6 registrational trial in generalized myasthenia gravis.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL8nmLtP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BGHQF748.EUR","SG9999014005.SGD","NDAQ","IE00BKPKM429.USD","IE00B64PRP62.GBP","LU2210150020.SGD","BK4585","BK4112","IE00B3QW5Z07.USD","LU0314104364.USD","SG9999014013.SGD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","SG9999014039.USD","BK4588","IE00BN0W2W23.USD","KYTX","SG9999014021.USD","LU2210149790.SGD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635242055","title":"Kyverna Therapeutics Announces Initiation of Rolling SPS BLA Submission and Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2635242055","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635242055?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:02","pubTimestamp":1778616120,"startTime":"0","endTime":"0","summary":"Positive pre-BLA meeting with FDA alignment reached on KYSA-8 single-arm trial in stiff person syndrome (SPS); rolling BLA submission initiated Miv-cel pivotal trial primary analysis results in SPS de","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3293353/0/en/Kyverna-Therapeutics-Announces-Initiation-of-Rolling-SPS-BLA-Submission-and-Reports-First-Quarter-2026-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","CRS","BK4178","LU0971096721.USD","HCP","IE00BKVL7J92.USD","LU0149725797.USD","LU2065731478.USD","LU2237443978.SGD","BK4006","BK4187","BK4023","LU1363072403.SGD","IE00B7SZL793.SGD","IE00B19Z4B17.USD","LU0963586101.USD","LU2237443465.HKD","KYTX","LU0170899867.USD","BK4588","LD","LU2746668461.USD","LU2237443382.USD","IE00BHPRN162.USD","BK4230","IE0031619046.USD","CAR","CSF","LU2746668974.SGD","BK4139","AAN","BK4022","IE00B1BXHZ80.USD","IE00BFXG1179.USD","IE00B66KJ199.SGD","LU2237443622.USD","LU2237443895.HKD","LU0882574139.USD","CMC","LU2237443549.SGD","BK4585","LU0267386448.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633511394","title":"Kyverna Therapeutics Inc  expected to post a loss of 75 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2633511394","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633511394?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:10","pubTimestamp":1778245810,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics Inc  expected to post a loss of75cents a share - Earnings Preview Kyverna Therapeutics Inc KYTX.OQ KYTX.O is expected to  show no change in quarterly revenue when it reports  resu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L1GG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KYTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633615273","title":"Kyverna Therapeutics Chief Commercial Officer Nadia Dac files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2633615273","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633615273?lang=en_us&edition=fundamental","pubTime":"2026-05-07 04:33","pubTimestamp":1778099609,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics filed an initial beneficial ownership statement for Chief Commercial Officer Nadia Dac.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kyverna Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 06, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDLbNgdX1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632795897","title":"Press Release: Kyverna Therapeutics Appoints Nadia Dac, Seasoned Commercial Leader in Neurology and Rare Disease, as Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2632795897","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632795897?lang=en_us&edition=fundamental","pubTime":"2026-05-04 20:00","pubTimestamp":1777896000,"startTime":"0","endTime":"0","summary":"EMERYVILLE, Calif., May 04, 2026  -- Kyverna Therapeutics, Inc. , a late-stage clinical biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced the appointment of veteran commercial leader Nadia Dac as Chief Commercial Officer, effective May 4.Ms. Dac most recently served as Chief Commercial Officer at Omeros Corporation, where she built and led the commercial organization for rare disease programs in hematologic and immune-mediated conditions, including the launch of Yartemlea , the first FDA-approved treatment for hematopoietic stem cell transplant-associated thrombotic microangiopathy. Prior to Omeros, she served as CCO at Alder Biopharmaceuticals, Inc., where she led the commercial launch of Vyepti in migraine prevention, prior to the company's acquisition by Lundbeck.Earlier in her career, Ms. Dac held roles of increasing responsibility at Novartis, building the commercial infrastructure that effectively launched Gileny","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4232","R","BK4022","KYTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629880978","title":"Kyverna Therapeutics Price Target Maintained With a $20.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2629880978","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629880978?lang=en_us&edition=fundamental","pubTime":"2026-04-23 18:29","pubTimestamp":1776940140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/KYTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 23, 2026 06:29 ET (10:29 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629887036","title":"Kyverna Therapeutics: Strong CAR‑T Efficacy and Safety in SPS and gMG Underpin Buy Rating and $20 Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2629887036","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629887036?lang=en_us&edition=fundamental","pubTime":"2026-04-23 18:15","pubTimestamp":1776939339,"startTime":"0","endTime":"0","summary":"Analyst Mitchell Kapoor of H.C. Wainwright reiterated a Buy rating on Kyverna Therapeutics, Inc., retaining the price target of $20.00. Mitchell Ka...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/kyverna-therapeutics-strong-car‑t-efficacy-and-safety-in-sps-and-gmg-underpin-buy-rating-and-20-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/kyverna-therapeutics-strong-car‑t-efficacy-and-safety-in-sps-and-gmg-underpin-buy-rating-and-20-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KYTX","CAR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629211910","title":"BUZZ-U.S. STOCKS ON THE MOVE-Tesla, AT&T, Yesway","url":"https://stock-news.laohu8.com/highlight/detail?id=2629211910","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629211910?lang=en_us&edition=fundamental","pubTime":"2026-04-23 02:01","pubTimestamp":1776880908,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Tesla, AT&T, YeswayWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nL6N4150PB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BSX","TH","BOEG","HL","NVR","PM","KYTX","OTIS","YSWY","TSLY","ISRG","MAZE","MSTK","BOED","BA","3LMI.UK","07799","TFX","WAB","HLTC","TSLA","DGX","TWLO","T","CDE","CERT","MSTP","COIN","INBX","BBY","RIOT","DJT","MSTR","HOOD","NKTR","STX","SPWR","GEV","TSLS","07766","NEM","ADBE","DHR","HLXX","TEL","AMRX","IMST","NWMX","CALX","MAS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629428690","title":"Kyverna Therapeutics Shares Rise 7.3% After Co's Rare Muscle Disorder Cell Therapy Shows Strong Mid-Stage Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2629428690","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629428690?lang=en_us&edition=fundamental","pubTime":"2026-04-22 21:32","pubTimestamp":1776864759,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nL4N4151IM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KYTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629504374","title":"BUZZ-U.S. STOCKS ON THE MOVE-Adobe, GE Vernova, Calix","url":"https://stock-news.laohu8.com/highlight/detail?id=2629504374","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629504374?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:37","pubTimestamp":1776857863,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Adobe, GE Vernova, CalixWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nL6N4150TF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2462611646.USD","LU2125909247.SGD","LU1868836591.USD","DJT","LU0528227936.USD","BK4592","GB00BDT5M118.USD","LU2210149790.SGD","LU2264538146.SGD","IE000M9KFDE8.USD","LU1868837565.USD","LU0238689110.USD","BK4554","LU2112291526.USD","BK4121","BK4196","LU1978683503.SGD","LU1201861165.SGD","LU0057025933.USD","LU0289960550.SGD","IE00B894F039.SGD","BK4551","BK4007","LU1280957306.USD","LU0081259029.USD","LU0868494617.USD","SGXZ99366536.SGD","LU0820561909.HKD","LU1223083913.SGD","LU1983299246.USD","LU0203345920.USD","BK4522","LU0234572021.USD","LU1366192091.USD","LU2125910336.SGD","LU0314104364.USD","BK4512","LU1923622614.USD","LU1674673428.USD","BK4566","LU1435385759.SGD","LU1861219969.SGD","BK4567","IE00B19Z8X17.USD","LU0330918003.SGD","LU0792757196.USD","LU1854104046.USD","BK4570","LU0348723411.USD","LU2357305700.SGD","LU1691799644.USD","IE00BQXX3D17.EUR","LU0557290698.USD","IE00BZ9MQY76.HKD","LU1778281490.HKD","BK4077","LU0114720955.EUR","IE00B19Z8W00.USD","BK4182","GFI","BOEG","LU0345780521.USD","LU0058720904.USD","LU0823416689.USD","LU2249611893.SGD","LU0266512473.USD","LU0950375773.USD","LU1061106388.HKD","LU0823434583.USD","LU1868837136.USD","LU1223082519.USD","LU1093756168.USD","LU2023251221.USD","LU1923621640.USD","SG9999004303.SGD","LU0345780950.USD","LU2236285917.USD","LU2506952170.USD","LU2095319765.USD","SGXZ81514606.USD","LU0300736492.USD","LU1548497426.USD","LU0170899867.USD","LU0130103400.USD","TFX","LU1023059493.AUD","LU1983260115.SGD","BK4581","LU0648000940.SGD","BK4547","BK4082","LU1084165304.USD","IE00BKVL7J92.USD","LU0345781412.USD","GEV","LU1791710582.SGD","LU0345780281.USD","LU0943347566.SGD","LU1057294990.SGD","LU1235294995.USD","LU0511384066.AUD","LU0965509010.AUD","LU2125910179.SGD","LU1551013342.USD","LU0689472784.USD","IE00BFXG0V08.USD","LU0368265764.SGD","LU0823417737.USD","SG9999001424.SGD","IE0004445239.USD","ADBE","SG9999001143.SGD","DGX","LU0143863784.USD","LU1633808545.USD","BK4528","LU2413666699.HKD","LU0354030511.USD","DHR","BK4527","LU0109391861.USD","LU0708995401.HKD","BK4533","LU2458330169.SGD","BOEU","LU2298064838.USD","BK4504","LU1674673691.USD","LU0198837287.USD","LU2065170008.USD","LU1366333091.USD","LU0124676726.USD","IE0004091025.USD","LU2125154935.USD","LU0719512351.SGD","LU0456854461.SGD","LU0496367417.USD","LU0820561818.USD","LU1939255532.USD","LU1303367103.USD","LU0640476718.USD","BK4207","LU1868837300.USD","LU0061474960.USD","SG9999001176.SGD","LU0861579265.USD","ISUL","IE00B5TLWC47.USD","LU2506951792.HKD","LU0266512127.USD","LU2433249047.HKD","HMY","LU0079474960.USD","IE0034235188.USD","EXK","LU1989764664.SGD","LU0289739343.SGD","LU1720051108.HKD","BK4145","LU1989764748.USD","LU0788108826.HKD","IE00BZ1G4Q59.USD","LU1267930730.SGD","CALX","CDE","LU0347712357.USD","AMRX","IE0002270589.USD","LU0278409577.USD","LU2237438978.USD","IE00BD6J9T35.USD","LU1868838027.USD","LU2089283258.USD","LU0345774391.USD","BK4543","IE00BQXX3F31.USD","IE00B19Z9505.USD","LU0302445910.USD","LU2065171311.SGD","LU2023250504.SGD","LU1815333072.USD","BK4170","LU0069063385.USD","LU0477156797.USD","BK4532","IE00B19Z3581.USD","LU2065169927.USD","LU0175139822.USD","LU1988902786.USD","SGXZ23171101.USD","HL","LU2324357040.USD","SG9999000418.SGD","LU2317271919.USD","LU0630314457.HKD","LU0889565833.HKD","BK4564","LU1119994496.HKD","LU0820562030.AUD","LU1823568750.SGD","LU1223082196.USD","LU2413666426.HKD","LU0724618789.USD","BK4139","BK4583","LU0109392836.USD","LU2211814178.USD","SG9999001176.USD","BK4585","IE00B19Z9P08.USD","LU2125154778.USD","IE00B19Z3B42.SGD","LU1429558221.USD","TEL","LU0345774631.USD","LU0654597011.USD","LU1623119135.USD","BK4588","LU2458330243.SGD","NEMG","LU0498741890.SGD","BK4210","BK4548","LU0055631609.USD","LU1854103824.USD","LU1267930813.SGD","LU0289961442.SGD","LU0157215616.USD","LU0234570918.USD","LU0390134368.USD","SVM","LU0107464264.USD","LU0882574055.USD","LU2023250843.SGD","BK4020","LU0823434740.USD","LU0187121727.USD","IE00BQXX3C00.GBP","LU0889566641.SGD","LU1951198990.SGD","LU0612318385.USD","LU2098885051.SGD","GEVG","LU1046421795.USD","LU0158827948.USD","LU2298322129.HKD","LU2506951958.HKD","LU2506951875.HKD","LU0788109121.HKD","LU0965509101.SGD","LU2244417387.USD","LU1861214812.USD","DJTU","LU0061475181.USD","LU2089284900.SGD","IE00BZ199S13.USD","HLXX","LU1064131342.USD","LU0106261372.USD","LU0868494708.USD","LU0724618433.USD","BK4023","IE00B19Z9Z06.USD","LU0689626769.HKD","IE0004086264.USD","BK4187","LU0203347892.USD","LU0472753341.HKD","LU0143863198.USD","STX","LU1023059063.AUD","LU1720051017.SGD","ADBG","ISRG","LU2210150020.SGD","LU2106854487.HKD","SGXZ51526630.SGD","LU2063271972.USD","SG9999013999.USD","LU1551013425.SGD","LU0320765059.SGD","LU1951200564.SGD","LU0823414478.USD","IE00BYQQ9H92.USD","LU1721428933.USD","LU0823417653.USD","LU1868836757.USD","IE0009356076.USD","LU2506952097.USD","LU0289739699.SGD","LU2294711713.HKD","LU0957791311.USD","LU2360032135.SGD","LU0612318971.USD","LU1093756325.SGD","TH","LU1917777945.USD","LU2125909593.SGD","LU2355687059.USD","BK4534","LU0124384867.USD","LU2265009873.SGD","LU0300736062.USD","LU1883866441.USD","LU0130518102.USD","LU1712237335.SGD","BK4516","LU0096364046.USD","LU0965509283.SGD","TRUMP.USD.CC","LU0006306889.USD","LU1670627923.USD","NEM","BK4580","AU","LU2065171402.SGD","LU0082616367.USD","LU0942090050.USD","LU2238339852.HKD","LU1670628061.USD","LU1791710400.SGD","LU0312595415.SGD","LU2498475776.HKD","NWMX","LU1803068979.SGD","LU1923623000.USD","LU0432979614.USD","BOED","LU0122379950.USD","LU2326559502.SGD","LU0075056555.USD","LU1804176565.USD","LU1974910355.USD","SGXZ57979304.SGD","LU0672654240.SGD","LU2357125470.USD","BA","LU0097036916.USD","LU1430597077.USD","LU2360107325.USD","BK4017","KYTX","LU0498741114.HKD","LU1868836914.USD","GEVX","LU2275660780.HKD","LU0342679015.USD","LU1261432733.SGD","LU0823414551.USD","LU0354030438.USD","BK4142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629043456","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2629043456","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629043456?lang=en_us&edition=fundamental","pubTime":"2026-04-22 19:34","pubTimestamp":1776857688,"startTime":"0","endTime":"0","summary":"Huachen AI Parking Management Technology  shares were up 52% in Wednesday premarket activity, adding to Tuesday's gain.Poet Technologies  stock was 20% higher, extending gains from the previous session.Kyverna Therapeutics  shares were up 14% after the company reported overnight that a single dose of miv-cel in its KYSA-8 study \"delivered rapid, statistically significant and clinically meaningful improvements\" throughout all primary and secondary endpoints at 16 weeks.Adobe  stock was 3.1% higher, a day after the company said its board approved a new share buyback authorization, giving the company authority to buy back up to $25 billion in shares through April 30, 2030.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SGXZ81514606.USD","IE00BQXX3D17.EUR","LU0198837287.USD","LU0345774391.USD","LU1119994496.HKD","IE0009356076.USD","LU0061474960.USD","BK4534","LU1823568750.SGD","LU2089284900.SGD","LU1366333091.USD","BK4566","BK4585","LU1712237335.SGD","BK4139","LU0511384066.AUD","LU0106261372.USD","LU1235294995.USD","BK4592","IE00BQXX3F31.USD","POET","LU2023251221.USD","BK4533","LU0342679015.USD","LU1548497426.USD","LU0957791311.USD","BK4567","LU2210150020.SGD","LU1084165304.USD","LU1720051108.HKD","LU2317271919.USD","LU0889565833.HKD","LU0289961442.SGD","LU1261432733.SGD","BK4141","LU1815333072.USD","LU0965509101.SGD","LU2089283258.USD","LU2458330243.SGD","LU0320765059.SGD","LU0557290698.USD","LU1633808545.USD","LU2095319765.USD","LU0057025933.USD","IE00BYQQ9H92.USD","SGXZ51526630.SGD","LU2360032135.SGD","LU0965509010.AUD","LU0868494617.USD","LU0472753341.HKD","LU2237438978.USD","LU0082616367.USD","LU0006306889.USD","BK4528","BK4527","HCAI","LU2125154778.USD","LU0157215616.USD","BK4543","BK4554","LU0081259029.USD","LU1674673691.USD","LU0942090050.USD","LU0345774631.USD","LU2236285917.USD","LU0314104364.USD","LU0868494708.USD","LU0889566641.SGD","BK4588","LU0792757196.USD","LU0861579265.USD","KYTX","LU1803068979.SGD","LU1720051017.SGD","LU0234572021.USD","BK4149","IE00BFXG0V08.USD","LU0069063385.USD","LU0158827948.USD","SG9999000418.SGD","LU0234570918.USD","LU2458330169.SGD","LU2125154935.USD","LU0708995401.HKD","LU0672654240.SGD","LU0348723411.USD","SGXZ99366536.SGD","IE00B19Z9505.USD","LU1778281490.HKD","LU0719512351.SGD","LU2357305700.SGD","LU1267930813.SGD","LU0109391861.USD","ADBG","BK4581","LU0965509283.SGD","LU1046421795.USD","LU1674673428.USD","LU0109392836.USD","LU1267930730.SGD","LU1623119135.USD","IE00BQXX3C00.GBP","IE00B5TLWC47.USD","ADBE","LU0289739343.SGD","LU2210149790.SGD","SG9999001424.SGD","LU0170899867.USD","BK4023","LU1691799644.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629017990","title":"Kyverna Shares Rise Premarket After Promising Trial of Neurological Product","url":"https://stock-news.laohu8.com/highlight/detail?id=2629017990","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629017990?lang=en_us&edition=fundamental","pubTime":"2026-04-22 18:35","pubTimestamp":1776854100,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics' stock was higher before the market's open after a treatment for a rare neurological condition showed promise in a mid-stage clinical trial.Shares of Kyverna were up 20% at $11.68 in premarket trading.The Emeryville, Calif., biotechnology company said its mivocabtagene autoleucel, or KYV-101, product was tested on patients with stiff person syndrome in a phase II trial. After 16 weeks on the treatment, the majority of the 26 patients with the autoimmune condition regained function and one-third of them were able to walk at a typical adult speed.\"We see compelling evidence that a one-time therapy can reset the immune system, reverse the course of disease, and free patients from lifelong treatment burden,\" said Chief Executive Warren Biddle, in a statement.Canadian singer Celine Dion suffers from stiff person syndrome and supports research into the neurological condition. The lead investigator for the trial, Dr. Amanda Piquet, is the Celine Dion Foundation endowed ch","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KYTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629017506","title":"BUZZ-Kyverna jumps as rare muscle disorder cell therapy shows strong mid-stage results","url":"https://stock-news.laohu8.com/highlight/detail?id=2629017506","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629017506?lang=en_us&edition=fundamental","pubTime":"2026-04-22 18:33","pubTimestamp":1776854017,"startTime":"0","endTime":"0","summary":"BUZZ-Kyverna jumps as rare muscle disorder cell therapy shows strong mid-stage results** Shares of biotech firm Kyverna Therapeutics KYTX.O jump 20.6% to $11.71 premarket** Co says its experimental cell therapy miv-cel showed strong results in a mid-stage study for stiff person syndrome, a rare neurological disorder that causes severe muscle stiffness and painful spasms** Co says a single dose led to rapid and lasting improvements in walking and mobility for most patients in the trial** Says 81% of patients saw meaningful gains in walking speed, while about two-thirds no longer needed walking aids after 16 weeks** Says all patients were able to stop immune-suppressing drugs, the current standard treatment that often provides limited relief** Says the therapy was generally well tolerated, with some manageable side effects such as temporary low white blood cell counts** As of last close, stock up ~3% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nL4N4150Z6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KYTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629012198","title":"Kyverna Therapeutics Shares Jump 21% Premarket After Co's Therapy Improves Mobility in Mid-Stage Stiff Person Syndrome Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2629012198","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629012198?lang=en_us&edition=fundamental","pubTime":"2026-04-22 18:18","pubTimestamp":1776853093,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nFWN41506Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KYTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629092056","title":"Kyverna Therapeutics (KYTX) Stock Surges 24% After Hours: Why Is It Moving?","url":"https://stock-news.laohu8.com/highlight/detail?id=2629092056","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629092056?lang=en_us&edition=fundamental","pubTime":"2026-04-22 14:44","pubTimestamp":1776840248,"startTime":"0","endTime":"0","summary":"Kyverna Therapeutics Inc. shares surged 24% after hours following positive registrational trial results for miv-cel in stiff person syndrome, showing significant improvement in walking speed.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/04/51960000/kyverna-therapeutics-kytx-stock-surges-24-after-hours-why-is-it-moving","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4150","BK4139","OPEX","KYTX","BK4562","BK4561","BK4079","OPEG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629017066","title":"BRIEF-Kyverna Therapeutics Announces Positive Primary Analysis Results From KYSA-8 Trial Of Miv-Cel In SPS","url":"https://stock-news.laohu8.com/highlight/detail?id=2629017066","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629017066?lang=en_us&edition=fundamental","pubTime":"2026-04-22 06:51","pubTimestamp":1776811911,"startTime":"0","endTime":"0","summary":"BRIEF-Kyverna Therapeutics Announces Positive Primary Analysis Results From KYSA-8 Trial Of Miv-Cel In SPSApril 22 (Reuters) - Kyverna Therapeutics Inc KYTX.O:KYVERNA THERAPEUTICS INC - ANNOUNCES POSI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nFWN41414C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KYTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629066019","title":"Kyverna Therapeutics Inc - Trial Meets All Secondary Endpoints With Significant Improvements in SPS","url":"https://stock-news.laohu8.com/highlight/detail?id=2629066019","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629066019?lang=en_us&edition=fundamental","pubTime":"2026-04-22 06:50","pubTimestamp":1776811827,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nFWN41414C:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["KYTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629066012","title":"Kyverna Therapeutics Inc - Announces Positive Primary Analysis Results From Kysa-8 Trial of Miv-Cel in SPS","url":"https://stock-news.laohu8.com/highlight/detail?id=2629066012","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629066012?lang=en_us&edition=fundamental","pubTime":"2026-04-22 06:50","pubTimestamp":1776811827,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nFWN41414C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","KYTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":89,"code":"91000000","status":"200"}]}}